An experimental feasibility study on the use of scattering foil free beams for modulated electron radiotherapy

Abstract

The potential benefit of using scattering foil free beams for delivery of modulated electron radiotherapy is investigated in this work. Removal of the scattering foil from the beamline showed a measured bremsstrahlung tail dose reduction just beyond R(p) by a factor of 12.2, 6.9, 7.4, 7.4 and 8.3 for 6, 9, 12, 16 and 20 MeV beams respectively for 2 × 2 cm(2) fields defined on-axis when compared to the clinical beamline. Monte Carlo simulations were matched to measured data through careful tuning of source parameters and the modification of certain accelerator components beyond the manufacturer's specifications. An accelerator model based on the clinical beamline and one with the scattering foil removed were imported into a Monte Carlo-based treatment planning system (McGill Monte Carlo Treatment Planning). A treatment planning study was conducted on a test phantom consisting of a PTV and two distal organs at risk (OAR) by comparing a plan using the clinical beamline to a plan using a scattering foil free beamline. A DVH comparison revealed that for quasi-identical target coverage, the volume of each OAR receiving a given dose was reduced, thus reducing the dose deposited in healthy tissue.